Source:http://linkedlifedata.com/resource/pubmed/id/21491376
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-4-14
|
pubmed:abstractText |
Chronic antipsychotic drug treatment may cause tardive dyskinesia (TD), a long-term movement disorder. Gamma-aminobutyric acid (GABA) agonist drugs, which have intense sedative properties and may exacerbate psychotic symptoms, have been used to treat TD.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD000203
|
pubmed:dateRevised |
2011-6-16
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
|
pubmed:affiliation |
Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|